BioInvent, R&D Day, 2022
December 8th 2022 14:00 (Europe/Stockholm)
Language: English
Moderator: Journalist Lars Frick (Börsveckan)
Venue: Epicenter Store, Regeringsgatan 61A, Stockholm
Sector: Health care - Pharmaceuticals & Biotechnology
Listing: Mid Cap
Activity: Capital Markets Seminar
Presenters
KOL Dr Sean Lim
- Associate Professor and Honorary Consultant in Hematological Oncology at University Hospital Southampton
- Practicing clinician specializing in lymph node cancers
- Leads a scientific research group focusing on the development of new anti-cancer drugs, in particular novel therapeutic monoclonal antibodies
Andres McAllister, CMO
- CMO BioInvent since 2017
- Previously CSO at Debiopharm; senior roles at IDM and BioMerieux/Pierre Fabre
- PhD from Pasteur Institute, Paris
- MD from Universidad del Rosario, Bogotá
Björn Frendéus, CSO
- CSO BioInvent since 2014
- Graduated from the Swedish Foundation for Strategic Research funded Biomedicine programs within the Infection & Vaccinology program.
- Visiting Professor at University of Southampton
Martin Welschof, CEO
- BioInvent CEO since 2018
- Previously Director Technology Axaron Biosience; CEO Affitech, CEO Opsona Therapeutics
- Board member: APIM Therapeutics, Nextera AS and Uni Targeting Research
- Ph.D. in recombinant antibody technology